Ledger.Open graph →
SEC Form D · filed July 28, 2017

Rebound Therapeutics Corp

Offering
$16.5M
Sold
$16.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
IRVINE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Isaac Chalal · San Francisco, CAExec · DirectorTodd B. Stoller · Austin, TXExecBrent Zimmerman · CLEVELAND, OHExec · DirectorJerome A. Zeldis · Boston, MAExecRichard J. Tait · REDMOND, WAExec · DirectorChristopher T. Lambrix · Wayne, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗